Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-κB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance

Meng Wang, Guimei Li, Guiyang Jiang, Jingyuan Cai, Wentian Zhong, Ri-Zhen Huang, Zhikun Liu, Xiaochao Huang, Heng‐Shan Wang, Xiaochao Huang, Heng‐Shan Wang